Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Cancers|October 14, 2022
Cancer as a Channelopathy-Appreciation of Complimentary Pathways Provides a Different Perspective for Developing TreatmentsHarry J Gould, Dennis PaulTherapeutics and Clinical Risk Management|November 7, 2015
Critical appraisal of extended-release hydrocodone for chronic pain: patient considerationsHarry J Gould, Dennis PaulBiomedicines|April 23, 2022
Targeted Osmotic Lysis: A Novel Approach to Targeted Cancer TherapiesHarry J Gould, Dennis PaulPharmacological Research|October 11, 2014
Hydrocodone extended-release: pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversyHarry J Gould, Dennis PaulPain Medicine (Malden, Mass.)|August 26, 2010
Insulin is essential for the recovery from allodynia induced by complete Freund's adjuvantGregory P Casey, Dennis Paul, Harry J GouldCurrent Opinion in Anaesthesiology|July 11, 2007
Medications of abuse in pain managementMarcia R Flugsrud-Breckenridge, Clifford Gevirtz, Dennis Paul, et al.Cells|October 27, 2022
Effect of Cell Cycle on Cell Surface Expression of Voltage-Gated Sodium Channels and Na+,K+-ATPaseSamantha Edenfield, Abigail M Sims, Constance Porretta, et al.Oncotarget|April 13, 2018
Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumpsHarry J Gould, Jack Norleans, T David Ward, et al.Pain Medicine (Malden, Mass.)|May 8, 2010
Ranolazine attenuation of CFA-induced mechanical hyperalgesiaGregory P Casey, Jomar S Roberts, Dennis Paul, et al.Behavioural Pharmacology|September 24, 2009
Ranolazine attenuates behavioral signs of neuropathic painHarry J Gould, Colleen Garrett, Renee R Donahue, et al.Pageof 8